Pharma News, 2015

Recent weeks have not been friendly to the pharmaceutical industry, with some stocks in the sector such as Valeant Pharmaceuticals (NYSE.

Roche ($RHHBY) will close four plants and lay off 1,200 people as it moves toward more biologics and new specialized small-molecule drugs that require less capacity.

RIDGEFIELD, CT, USA I November 10, 2015 I Boehringer Ingelheim today announced it has completed enrollment for the pivotal Phase III trial (NCT02137226) of BI695501, a biosimilar candidate to ...

Human pluripotent stem cells (hPSC) can become any type of cell in the adult body, offering great potential in disease modeling, drug discovery and creating replacement cells for conditions ra...

AstraZeneca's experimental lupus drug anifrolumab significantly cut disease activity in a mid-stage clinical trial, boosting hopes for a medicine the company believes could become a $1 billion-a-y...

In a major scientific breakthrough, a drug used to treat Parkinson's and related diseases may be able to delay or prevent macular degeneration, the most common form of blindness among older Americ...

Embattled Valeant Pharmaceuticals may be coming around to the idea of selling itself.

ORLANDO, Fla.

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, has received a "warning letter" from U.

A team of scientists has identified a new chemical that can be used in eye drops to reverse cataracts which are a leading cause of blindness worldwide.

CBL0137Melbourne.

HSINCHU, Taiwan I November 05, 2015 I TaiwanJ Pharmaceuticals (6549.